Comparison of the anxiety and depression levels of pregnant women with COVID-19 and healthy pregnant women

INTRODUCTION: In our study, it was planned to examine the anxiety and depression levels of pregnant women diagnosed with covid 19, the sociodemographic characteristics that may be associated, and the change in anxiety and depression levels after the disease regressed.

METHODS: There were a total of 158 participants, including 63 patients and 95 controls participating in the study. The mean age was 28.61+/- 6.47 years. Pregnant women with COVID-19 and recommended follow-up and treatment between May 2020 and August 2020 were included in the study. Sociodemographic data form, Beck Depression Scale, Beck Anxiety Scale, State and Trait Anxiety Scale prepared by researchers were filled with patients who volunteered to participate in the study. The scales indicated were repeated when the patients came to their first check-up after fifteen days from discharge.

RESULTS: There is a statistically significant difference between the COVID-19 diagnostic groups in terms of Anxiety score (p <0.05). While the anxiety level was the highest in the COVID-19 positive diagnosis group (10.38), it was lower in the COVID-19 positive control group (5.7).
There is a statistically significant difference between the COVID-19 diagnostic groups in terms of Depression score (p <0.05). While the Depression level was highest in the COVID-19 positive diagnosis group (9.51), it was lower in the COVID-19 positive control group (5.8).

DISCUSSION AND CONCLUSION: This study showed us that COVID-19 infection increases anxiety and depression in pregnant women, and anxiety and depression are highest at the first diagnosis of the disease, especially in pregnant women with COVID-19.